9月16日,华润双鹤旗下新特药泛欣®巯嘌呤片(Ⅱ)在京东健康全网独家首发。该药品是国内首个获批上市的微型片剂巯嘌呤,专为儿童白血病患者设计,具备剂量精准、易于服用等特点。作为“新特药全网首发第一站”,京东健康将充分助力提升这款药品的可及性,让更多患者早日受益。儿童急性淋巴细胞白血病(ALL)已成为可治愈的恶性肿瘤之一,巯嘌呤作为指南推荐一线治疗药物,在临床使用中,也面临诸多问题与挑战,长期存在“...
Source Link9月16日,华润双鹤旗下新特药泛欣®巯嘌呤片(Ⅱ)在京东健康全网独家首发。该药品是国内首个获批上市的微型片剂巯嘌呤,专为儿童白血病患者设计,具备剂量精准、易于服用等特点。作为“新特药全网首发第一站”,京东健康将充分助力提升这款药品的可及性,让更多患者早日受益。儿童急性淋巴细胞白血病(ALL)已成为可治愈的恶性肿瘤之一,巯嘌呤作为指南推荐一线治疗药物,在临床使用中,也面临诸多问题与挑战,长期存在“...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.